Cargando…

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients

Stem cell transplant recipients (SCTR) are imperiled to increased risks after SARS-CoV2 infection, supporting the need for effective vaccination strategies for this vulnerable group. With respect to pediatric patients, data on immunogenicity of SARS-CoV2 mRNA-based vaccination is limited. We therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thole, Linda Marie Laura, Tóth, Laura, Proß, Vanessa, Siegle, Janine, Stahl, Carolin, Hermsdorf, Georg, Knabe, Annette, Winkler, Annika, Schrezenmeier, Eva, Ludwig, Carolin, Eckert, Cornelia, Eggert, Angelika, Schrezenmeier, Hubert, Sattler, Arne, Schulte, Johannes H., Kotsch, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628529/ https://www.ncbi.nlm.nih.gov/pubmed/37942315 http://dx.doi.org/10.3389/fimmu.2023.1239519

Ejemplares similares

SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
por: Sattler, Arne, et al.
Publicado: (2022)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
por: Jahrsdörfer, Bernd, et al.
Publicado: (2022)

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
por: Stahl, David, et al.
Publicado: (2022)

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

Persistent but atypical germinal center reaction among 3(rd) SARS-CoV-2 vaccination after rituximab exposure
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents
por: Jahrsdörfer, Bernd, et al.
Publicado: (2021)

Phorbol-12-myristate-13-acetate is a potent enhancer of B cells with a granzyme B(+) regulatory phenotype
por: Veh, Johanna, et al.
Publicado: (2023)

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

Human CD27+ memory B cells colonize a superficial follicular zone in the palatine tonsils with similarities to the spleen. A multicolor immunofluorescence study of lymphoid tissue
por: Lettau, Marie, et al.
Publicado: (2020)

Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
por: Ronicke, Simon, et al.
Publicado: (2022)

Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
por: Höchsmann, Britta, et al.
Publicado: (2011)

Interactions of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) with the Immune System: Implications for Inflammation and Cancer
por: Beyer, Katharina, et al.
Publicado: (2019)

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021)

Day care for dementia patients from a family caregiver's point of view: A questionnaire study on expected quality and predictors of utilisation - Part II
por: Donath, Carolin, et al.
Publicado: (2011)

Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC)
por: Torregroza, Carolin, et al.
Publicado: (2021)

Serum C reactive protein predicts humoral response after BNT162b2 booster administration
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

CD27(+)IgD(−) B cells in the peripheral blood of colorectal cancer patients: on anti-tumor or tumor-protective mission?
por: Jahrsdörfer, Bernd, et al.
Publicado: (2014)

First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine – case report
por: Osmanodja, Bilgin, et al.
Publicado: (2021)

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
por: Tsamadou, Chrysanthi, et al.
Publicado: (2022)

Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration
por: Rapp, Anna E., et al.
Publicado: (2018)

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
por: Launspach, Michael, et al.
Publicado: (2021)

Labeling of mesenchymal stromal cells with iron oxide-poly(l-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties
por: Schmidtke-Schrezenmeier, Gerlinde, et al.
Publicado: (2011)

Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis
por: Sulejmani, Ornela, et al.
Publicado: (2021)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Greiner, Jochen, et al.
Publicado: (2023)

Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domain
por: Reiners, Nina, et al.
Publicado: (2021)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγ(c)(null) Mice
por: Rapp, Anna E., et al.
Publicado: (2016)

Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke
por: Hoyer, Carolin, et al.
Publicado: (2019)

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
por: Szymansky, Annabell, et al.
Publicado: (2021)

Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH Patients
por: Harder, Markus J., et al.
Publicado: (2019)

Altered increase in STAT1 expression and phosphorylation in severe COVID‐19
por: Rincon‐Arevalo, Hector, et al.
Publicado: (2021)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kedip770rl5cbn24eibpjju0v6